Header Logo

Connection

SUSAN HILSENBECK to Oncogene Protein v-akt

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Oncogene Protein v-akt.
SUSAN HILSENBECK
Connection Strength
0.024
Oncogene Protein v-akt
  1. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2011 Oct; 129(3):819-27.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.